PatchSiren cyber security CVE debrief
CVE-2026-19646 IBM CVE debrief
IBM Common Licensing Agent and ART products are vulnerable to a redirect vulnerability due to improper validation of the HTTP Host header, potentially allowing a remote attacker to redirect users to an arbitrary domain. This issue affects multiple product versions and requires verification and patching to prevent potential exploitation. Affected systems, particularly those exposed to the internet or used by multiple users, need to be assessed for vulnerability and prioritized for patching.
- Vendor
- IBM
- Product
- Common Licensing
- CVSS
- CRITICAL 9.1
- CISA KEV
- Not listed in stored evidence
- Original CVE published
- 2026-09-10
- Original CVE updated
- 2026-09-11
- Advisory published
- 2026-09-10
- Advisory updated
- 2026-09-11
Who should care
Defenders responsible for IBM Common Licensing Agent and ART products, particularly those exposed to the internet or used by multiple users, should assess their systems for potential vulnerability and prioritize patching.
Why it matters
Defenders should care about CVE-2026-19646 because it allows a remote attacker to redirect users to an arbitrary domain, potentially leading to phishing attacks, unauthorized access, or disruption of service. Affected systems, particularly those exposed to the internet or used by multiple users, require verification and patching to prevent potential exploitation.
- Potential for phishing attacks through redirects
- Risk of unauthorized access to sensitive information
- Possible disruption of service or user experience
- Need for verification of affected systems and patching
Technical summary
The vulnerability exists in IBM Common Licensing Agent 9.0, Agent 9.0.0.1, Agent 9.0.0.2, ART 9.0, ART 9.0.0.1, and ART 9.0.0.2 due to improper validation of the HTTP Host header. This allows a remote attacker to redirect users to an arbitrary domain, potentially leading to phishing attacks or unauthorized access. Defenders should prioritize verifying and patching affected systems, particularly those exposed to the internet or used by multiple users, to prevent potential exploitation.
Defensive priority
Defenders should prioritize verifying and patching affected systems, particularly those exposed to the internet or used by multiple users.
Recommended defensive actions
- Verify and apply patches for affected IBM Common Licensing Agent and ART products
- Restrict access to affected systems to trusted users only
- Monitor for suspicious activity or potential redirects
Evidence notes
The CVE record and NVD entry provide limited information about the vulnerability. Further verification is required to determine the full scope of affected systems and potential impact.
Sources and references
Verified primary and authoritative sources
-
CVE-2026-19646 CVE Program record
Publisher, destination, and source semantics verified
URL: https://www.cve.org/CVERecord?id=CVE-2026-19646
CVE Program - Official CVE Program record with source-provided CVE metadata.
-
CVE-2026-19646 NVD vulnerability detail
Publisher, destination, and source semantics verified
URL: https://nvd.nist.gov/vuln/detail/CVE-2026-19646
NIST National Vulnerability Database - Official NIST NVD detail page and source-specific vulnerability assessment.
Supplemental references
-
Source reference
Unverified legacy reference
URL: https://www.ibm.com/support/pages/node/7286490
Methodology and review provenance
AI-assisted synthesis based on stored public vulnerability evidence. System validation, approval state, and publication status do not by themselves establish human review of this revision. PatchSiren helps prioritize defensive review and does not prove exposure or remediation on any system.